Pinhata J, Ferrazoli L, Mendes F, Goncalves M, da Silva Rabello M, Ghisi K
Eur J Clin Microbiol Infect Dis. 2023; 43(1):73-85.
PMID: 37943394
DOI: 10.1007/s10096-023-04693-8.
Lungu P, Kerkhoff A, Kasapo C, Mzyece J, Nyimbili S, Chimzizi R
BMJ Open. 2021; 11(8):e044867.
PMID: 34376439
PMC: 8356169.
DOI: 10.1136/bmjopen-2020-044867.
Kim H, Lee S, Jo E, Kim S, Kim H, Kim E
Appl Microbiol Biotechnol. 2021; 105(14-15):6059-6072.
PMID: 34328537
DOI: 10.1007/s00253-021-11446-0.
Broda A, Nikolayevskyy V, Casali N, Khan H, Bowker R, Blackwell G
Eur J Clin Microbiol Infect Dis. 2018; 37(7):1273-1279.
PMID: 29675789
PMC: 6015100.
DOI: 10.1007/s10096-018-3246-2.
Mahomed S, Dlamini-Mvelase N, Dlamini M, Mlisana K
Afr J Lab Med. 2017; 6(1):537.
PMID: 28879150
PMC: 5516912.
DOI: 10.4102/ajlm.v6i1.537.
Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
Ahmad S, Mokaddas E, Al-Mutairi N, Eldeen H, Mohammadi S
PLoS One. 2016; 11(4):e0153563.
PMID: 27096759
PMC: 4838278.
DOI: 10.1371/journal.pone.0153563.
Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium.
Lakshmi R, Ramachandran R, Ravi Kumar D, Sundar A, Radhika G, Rahman F
Indian J Med Res. 2015; 142(5):538-42.
PMID: 26658587
PMC: 4743339.
DOI: 10.4103/0971-5916.171278.
Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
Dantas N, Suffys P, Carvalho W, Magdinier Gomes H, de Almeida I, de Assis L
BMC Infect Dis. 2015; 15:306.
PMID: 26231661
PMC: 4521345.
DOI: 10.1186/s12879-015-1057-y.
Comparison of the mycobacterium growth indicator tube method and the method of proportion for drug susceptibility testing of mycobacterium tuberculosis.
Aktas A, Yigit N, Ayyildiz A, Bastopcu A
Eurasian J Med. 2015; 46(2):96-101.
PMID: 25610306
PMC: 4261451.
DOI: 10.5152/eajm.2014.23.
Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.
Zhao P, Fang F, Yu Q, Guo J, Zhang J, Qu J
PLoS One. 2014; 9(9):e99659.
PMID: 25248118
PMC: 4172428.
DOI: 10.1371/journal.pone.0099659.
Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.
Gomathi N, Kumar V
Indian J Med Res. 2014; 139(3):471-3.
PMID: 24820845
PMC: 4069745.
Evaluation of the BD Bactec MGIT 320 system for detection of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis.
Duque A, Lin S, Desmond E, Rienthong S, Rienthong D, Boonin C
J Clin Microbiol. 2013; 51(10):3403-5.
PMID: 23863564
PMC: 3811643.
DOI: 10.1128/JCM.01357-13.
Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.
Said H, Kock M, Ismail N, Baba K, Omar S, Osman A
BMC Infect Dis. 2012; 12:369.
PMID: 23259765
PMC: 3543708.
DOI: 10.1186/1471-2334-12-369.
The manual mycobacteria growth indicator tube and the nitrate reductase assay for the rapid detection of rifampicin resistance of M. Tuberculosis in low resource settings.
Adikaram C, Perera J, Wijesundera S
BMC Infect Dis. 2012; 12:326.
PMID: 23186045
PMC: 3538674.
DOI: 10.1186/1471-2334-12-326.
Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.
Espasa M, Salvado M, Vicente E, Tudo G, Alcaide F, Coll P
J Clin Microbiol. 2011; 50(2):488-91.
PMID: 22135258
PMC: 3264154.
DOI: 10.1128/JCM.06432-11.
Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.
Sharma M, Thibert L, Chedore P, Shandro C, Jamieson F, Tyrrell G
J Clin Microbiol. 2011; 49(12):4112-6.
PMID: 21998413
PMC: 3232997.
DOI: 10.1128/JCM.05195-11.
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Khanna A, Raj V, Tarai B, Sood R, Pareek P, Upadhyay D
Antimicrob Agents Chemother. 2010; 54(11):4789-93.
PMID: 20713679
PMC: 2976148.
DOI: 10.1128/AAC.00661-10.
An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.
Balabanova Y, Drobniewski F, Nikolayevskyy V, Kruuner A, Malomanova N, Simak T
PLoS One. 2009; 4(9):e7129.
PMID: 19774085
PMC: 2744930.
DOI: 10.1371/journal.pone.0007129.
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
Lin S, Desmond E, Bonato D, Gross W, Siddiqi S
J Clin Microbiol. 2009; 47(11):3630-4.
PMID: 19741086
PMC: 2772628.
DOI: 10.1128/JCM.00803-09.
Molecular diagnostics in tuberculosis: basis and implications for therapy.
Balasingham S, Davidsen T, Szpinda I, Frye S, Tonjum T
Mol Diagn Ther. 2009; 13(3):137-51.
PMID: 19650669
DOI: 10.1007/BF03256322.